Charles Shapiro

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi Bone health in adult cancer survivorship
    Maryam B Lustberg
    Ohio State University, Columbus, OH 43210 1240, USA
    J Clin Oncol 30:3665-74. 2012
  2. ncbi The LIVESTRONG Survivorship Center of Excellence Network
    Charles L Shapiro
    Ohio State University Comprehensive Cancer Center, Starling Loving Hall, Columbus, OH 43210, USA
    J Cancer Surviv 3:4-11. 2009
  3. ncbi Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809
    C L Shapiro
    Ohio State University Medical Center and James Cancer Hospital, Columbus, OH 43210, USA
    Eur J Cancer 47:683-9. 2011
  4. ncbi Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer
    Mark D Pegram
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Avenue Suite 3400 D8 4, Miami, FL 33136, USA
    Breast Cancer Res 11:R73. 2009
  5. ncbi The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    S R Young
    Women s College Research Institute, Department of Public Health, The University of Toronto, Toronto, Canada
    BMC Cancer 9:86. 2009

Collaborators

  • S Halabi
  • H J Burstein
  • Lisa Diller
  • Mary S McCabe
  • Alfred C Marcus
  • Linda A Jacobs
  • Maryam B Lustberg
  • S R Young
  • Mark D Pegram
  • Raquel E Reinbolt
  • Song Li
  • JYOTSNA FULORIA
  • Franziska Schaedli Stark
  • Stephanie Cohen
  • Beverly Tenenholz
  • Virginia F Borges
  • Judith Miller
  • Inuk Zandvakili
  • Nuhad Ibrahim
  • Talia Donenberg
  • Nigel Courtenay Luck
  • Robert T Pilarski
  • Lyn S Hammond
  • Robert Royer
  • Karen Wang
  • Karen A Brooks
  • Damini Desai
  • Susan Perez
  • Steven A Narod

Detail Information

Publications5

  1. ncbi Bone health in adult cancer survivorship
    Maryam B Lustberg
    Ohio State University, Columbus, OH 43210 1240, USA
    J Clin Oncol 30:3665-74. 2012
    ..This review will summarize the mechanisms by which cancer treatments cause bone loss as well provide screening and treatment recommendations for the management of bone loss...
  2. ncbi The LIVESTRONG Survivorship Center of Excellence Network
    Charles L Shapiro
    Ohio State University Comprehensive Cancer Center, Starling Loving Hall, Columbus, OH 43210, USA
    J Cancer Surviv 3:4-11. 2009
    ..The Network was created to accelerate the pace of progress in addressing the needs of the growing survivor community...
  3. ncbi Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809
    C L Shapiro
    Ohio State University Medical Center and James Cancer Hospital, Columbus, OH 43210, USA
    Eur J Cancer 47:683-9. 2011
    ..We hypothesised that zoledronic acid (ZA), a third-generation amino bisphosphonate, would prevent bone loss in premenopausal women who developed CIOF...
  4. ncbi Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer
    Mark D Pegram
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Avenue Suite 3400 D8 4, Miami, FL 33136, USA
    Breast Cancer Res 11:R73. 2009
    ....
  5. ncbi The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    S R Young
    Women s College Research Institute, Department of Public Health, The University of Toronto, Toronto, Canada
    BMC Cancer 9:86. 2009
    ....